ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

被引：253

作者：

Cardoso, F. ^{[1
]}

Costa, A. ^{[2
,3
]}

Norton, L. ^{[4
]}

Senkus, E. ^{[5
]}

Aapro, M. ^{[6
]}

Andre, F. ^{[7
]}

Barrios, C. H. ^{[8
]}

Bergh, J. ^{[9
,10
,11
]}

Biganzoli, L. ^{[12
]}

Blackwell, K. L. ^{[13
]}

Cardoso, M. J. ^{[14
]}

Cufer, T. ^{[15
]}

El Saghir, N. ^{[16
]}

Fallowfield, L. ^{[17
]}

Fenech, D. ^{[18
]}

Francis, P. ^{[19
]}

Gelmon, K. ^{[20
]}

Giordano, S. H. ^{[21
,22
]}

Gligorov, J. ^{[23
]}

Goldhirsch, A. ^{[24
]}

Harbeck, N. ^{[25
]}

Houssami, N. ^{[26
]}

Hudis, C. ^{[27
]}

Kaufman, B. ^{[28
]}

Krop, I. ^{[29
]}

Kyriakides, S. ^{[30
]}

Lin, U. N. ^{[29
]}

Mayer, M. ^{[31
]}

Merjaver, S. D. ^{[32
,33
]}

Nordstrom, E. B. ^{[34
]}

Pagani, O. ^{[35
,36
]}

Partridge, A. ^{[37
]}

Penault-Llorca, F. ^{[38
]}

Piccart, M. J. ^{[39
]}

Rugo, H. ^{[40
]}

Sledge, G. ^{[41
]}

Thomssen, C. ^{[42
]}

van't Veer, L. ^{[43
]}

Vorobiof, D. ^{[44
]}

Vrieling, C. ^{[45
]}

West, N. ^{[46
]}

Xu, B. ^{[47
,48
]}

Winer, E. ^{[29
]}

机构：

[1] Champalimaud Canc Ctr, European Sch Oncol & Breast Unit, P-1400048 Lisbon, Portugal

[2] European Sch Oncol, Milan, Italy

[3] European Sch Oncol, Bellinzona, Switzerland

[4] Mem Sloan Kettering Canc Ctr, Breast Canc Program, New York, NY 10021 USA

[5] Med Univ Gdansk, Dept Radiotherapy & Oncol, Gdansk, Poland

[6] Inst Multidisciplinaire Oncol, Div Oncol, Genolier, Switzerland

[7] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France

[8] Pontificia Univ Catolica Rio Grande do Sul, Sch Med, Dept Med, Porto Alegre, RS, Brazil

[9] Karolinska Inst, Dept Oncol Radiumhemmet, Stockholm, Sweden

[10] Canc Ctr Karolinska, Stockholm, Sweden

[11] Karolinska Univ Hosp, Stockholm, Sweden

[12] Sandro Pitigliani Oncol Ctr, Dept Med Oncol, Prato, Italy

[13] Duke Canc Inst, Breast Canc Clin Program, Durham, NC USA

[14] Champalimaud Canc Ctr, Breast Unit, P-1400048 Lisbon, Portugal

[15] Univ Clin Golnik, Med Fac Ljubljana, Ljubljana, Slovenia

[16] Amer Univ Beirut, Med Ctr, NK Basile Canc Inst Breast Ctr Excellence, Beirut, Lebanon

[17] Univ Sussex, Brighton & Sussex Med Sch, Falmer, England

[18] Europa Donna Malta, Breast Care Support Grp, Mtarfa, Malta

[19] Peter MacCallum Canc Ctr, Div Canc Med, Melbourne, Vic, Australia

[20] BC Canc Agcy, Vancouver, BC, Canada

[21] UT MD Anderson Canc Ctr, Dept Hlth Serv Res, Houston, TX USA

[22] UT MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX USA

[23] IUC UPMC, APHP Tenon, Francilian Breast Intergrp, Paris, France

[24] European Inst Oncol, Program Breast Hlth, Milan, Italy

[25] Brustzentrum Univ Munchen, Munich, DE USA

[26] Univ Sydney, Sydney Med Sch, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia

[27] Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, New York, NY 10021 USA

[28] Sheba Med Ctr, Tel Hashomer, Israel

[29] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[30] Europa Donna Cyprus, Nicosa, Cyprus

[31] Adv BC org, New York, NY USA

[32] Univ Michigan, Sch Med, Ann Arbor, MI USA

[33] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA

[34] Europa Donna Sweden & Brostcancerforeningarnas Ri, BRO, Sundbyberg, Sweden

[35] Oncol Inst Southern Switzerland, Bellinzona, Switzerland

[36] Breast Unit Southern Switzerland, Bellinzona, Switzerland

[37] Dana Farber Canc Inst, Dept Med Oncol, Div Womens Canc, Boston, MA 02115 USA

[38] Ctr Comprehens Canc, Jean Perrin Ctr, Clermont Ferrand, France

[39] Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium

[40] UCSF, Helen Diller Family Comprehens Canc Ctr, Dept Med, Breast Oncol Program, San Francisco, CA USA

[41] Indiana Univ, Med Ctr, Indianapolis, IN USA

[42] Univ Halle Wittenberg, Dept Gynaecol, Halle, DE, Germany

[43] UCSF, Helen Diller Family Comprehens Canc Ctr, Breast Oncol Program, San Francisco, CA USA

[44] Sandton Oncol Ctr, Johannesburg, South Africa

[45] Clin Grangettes, Dept Radiotherapy, Geneva, Switzerland

[46] Cardiff & Vale Univ, Hlth Board, Nursing Div, Cardiff, S Glam, Wales

[47] Chinese Acad Med Sci, Canc Hosp, Dept Med Oncol, Beijing 100730, Peoples R China

[48] Peking Union Med Coll, Beijing 100021, Peoples R China

来源：

BREAST | 2014年 / 23卷 / 05期

关键词：

PHASE-III TRIAL; ISOLATED LOCOREGIONAL RECURRENCE; MIDDLE-INCOME COUNTRIES; FIRST-LINE THERAPY; POSTMENOPAUSAL WOMEN; PRIMARY TUMOR; DOUBLE-BLIND; PATIENT NAVIGATION; 1ST-LINE THERAPY; SYSTEMIC THERAPY;

D O I：

10.1016/j.breast.2014.08.009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：489 / 502

页数：14

共 131 条

[1]

Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial [J].

Aebi, Stefan ;

Gelber, Shari ;

Anderson, Stewart J. ;

Lang, Istvan ;

Robidoux, Andre ;

Martin, Miguel ;

Nortier, Johan W. R. ;

Paterson, Alexander H. G. ;

Rimawi, Mothaffar F. ;

Canada, Jose Manuel Baena ;

Thuerlimann, Beat ;

Murray, Elizabeth ;

Mamounas, Eleftherios P. ;

Geyer, Charles E., Jr. ;

Price, Karen N. ;

Coates, Alan S. ;

Gelber, Richard D. ;

Rastogi, Priya ;

Wolmark, Norman ;

Wapnir, Irene L. .

LANCET ONCOLOGY, 2014, 15 (02) :156-163

[2]

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study [J].

Alba, E. ;

Chacon, J. I. ;

Lluch, A. ;

Anton, A. ;

Estevez, L. ;

Cirauqui, B. ;

Carrasco, E. ;

Calvo, L. ;

Segui, M. A. ;

Ribelles, N. ;

Alvarez, R. ;

Sanchez-Munoz, A. ;

Sanchez, R. ;

Lopez Garcia-Asenjo, J. A. ;

Rodriguez-Martin, C. ;

Escudero, M. J. ;

Albanell, J. .

BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (02) :487-493

[3]

Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies [J].

Amir, Eitan ;

Clemons, Mark ;

Purdie, Colin A. ;

Miller, Naomi ;

Quinlan, Phil ;

Geddie, William ;

Coleman, Robert E. ;

Freedman, Orit C. ;

Jordan, Lee B. ;

Thompson, Alastair M. .

CANCER TREATMENT REVIEWS, 2012, 38 (06) :708-714

[4]

Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The HERNATA Study [J].

Andersson, Michael ;

Lidbrink, Elisabeth ;

Bjerre, Karsten ;

Wist, Erik ;

Enevoldsen, Kristin ;

Jensen, Anders B. ;

Karlsson, Per ;

Tange, Ulla B. ;

Sorensen, Peter G. ;

Moller, Susanne ;

Bergh, Jonas ;

Langkjer, Sven T. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (03) :264-271

[5]

Breast cancer with synchronous metastases: Trends in survival during a 14-year period [J].

Andre, F ;

Slimane, K ;

Bachelot, T ;

Dunant, A ;

Namer, M ;

Barrelier, A ;

Kabbaj, O ;

Spano, JP ;

Marsiglia, H ;

Rouzier, R ;

Delaloge, S ;

Spielmann, M .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3302-3308

[6]

[Anonymous], 2013 SAN ANT BREAST

[7]

[Anonymous], J NATL CANC I

[8]

[Anonymous], EBCC 9 2014 EV PLUS

[9]

[Anonymous], J CLIN ONCOL

[10]

[Anonymous], BMJ SUPPORT PALLI S1

← 1 2 3 4 5 6 7 8 9 10 →